Cargando…

Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic

OBJECTIVES: Little is known about how the coronavirus disease 2019 (COVID-19) pandemic affected influenza vaccine utilization and disparities. We sought to estimate changes in the likelihood of receiving an influenza vaccine across different demographic subgroups during the COVID-19 pandemic. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kun, Yu, Tianzhou, Seabury, Seth A., Dor, Avi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960160/
https://www.ncbi.nlm.nih.gov/pubmed/35370018
http://dx.doi.org/10.1016/j.vaccine.2022.03.058
_version_ 1784677328687726592
author Li, Kun
Yu, Tianzhou
Seabury, Seth A.
Dor, Avi
author_facet Li, Kun
Yu, Tianzhou
Seabury, Seth A.
Dor, Avi
author_sort Li, Kun
collection PubMed
description OBJECTIVES: Little is known about how the coronavirus disease 2019 (COVID-19) pandemic affected influenza vaccine utilization and disparities. We sought to estimate changes in the likelihood of receiving an influenza vaccine across different demographic subgroups during the COVID-19 pandemic. METHODS: In this cohort study, we analyzed influenza vaccine uptake from 2019 to 2020 using Optum commercial insurance claims data. Eligible individuals were aged 18 or above in 2018 and continuously enrolled from 08/01/2018 through 12/31/2020. Multivariable logistic regressions were fitted for the individual-level influenza vaccine uptake. Adjusting for demographic factors and medical histories, we estimated probabilities of receiving influenza vaccines before and after the COVID-19 pandemic across demographic subgroups. RESULTS: From August to December 2019, unadjusted influenza vaccination rate was 42.3%, while in the same period of 2020, the vaccination rate increased to 45.9%. Females had a higher vaccination rate in 2019 (OR: 1.16, 95% CI 1.15–1.16), but the increase was larger for males. Blacks and Hispanics had lower vaccination rates relative to whites in both flu seasons. Hispanics showed a greater increase in vaccination rate, increasing by 7.8 percentage points (p < .001) compared to 4.4 (p < .001) for whites. The vaccination rate for Blacks increased by 5.2 percentage points (p < .001). All income groups experienced vaccination improvements, but poorer individuals had lower vaccination rates in both seasons. The most profound disparities occurred when educational cohort were considered. The vaccination rate increased among college-educated enrollees by 8.8 percentage points (p < .001) during the pandemic compared to an increase of 2.8 percentage points (p < .001) for enrollees with less than a 12th grade education. Past influenza infections or vaccination increased the likelihood of vaccination (p < .001). CONCLUSIONS: The COVID-19 pandemic was associated with increased influenza vaccine utilization. Disparities persisted but narrowed with respect to gender and race but worsened with respect to income and educational attainment.
format Online
Article
Text
id pubmed-8960160
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89601602022-03-29 Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic Li, Kun Yu, Tianzhou Seabury, Seth A. Dor, Avi Vaccine Article OBJECTIVES: Little is known about how the coronavirus disease 2019 (COVID-19) pandemic affected influenza vaccine utilization and disparities. We sought to estimate changes in the likelihood of receiving an influenza vaccine across different demographic subgroups during the COVID-19 pandemic. METHODS: In this cohort study, we analyzed influenza vaccine uptake from 2019 to 2020 using Optum commercial insurance claims data. Eligible individuals were aged 18 or above in 2018 and continuously enrolled from 08/01/2018 through 12/31/2020. Multivariable logistic regressions were fitted for the individual-level influenza vaccine uptake. Adjusting for demographic factors and medical histories, we estimated probabilities of receiving influenza vaccines before and after the COVID-19 pandemic across demographic subgroups. RESULTS: From August to December 2019, unadjusted influenza vaccination rate was 42.3%, while in the same period of 2020, the vaccination rate increased to 45.9%. Females had a higher vaccination rate in 2019 (OR: 1.16, 95% CI 1.15–1.16), but the increase was larger for males. Blacks and Hispanics had lower vaccination rates relative to whites in both flu seasons. Hispanics showed a greater increase in vaccination rate, increasing by 7.8 percentage points (p < .001) compared to 4.4 (p < .001) for whites. The vaccination rate for Blacks increased by 5.2 percentage points (p < .001). All income groups experienced vaccination improvements, but poorer individuals had lower vaccination rates in both seasons. The most profound disparities occurred when educational cohort were considered. The vaccination rate increased among college-educated enrollees by 8.8 percentage points (p < .001) during the pandemic compared to an increase of 2.8 percentage points (p < .001) for enrollees with less than a 12th grade education. Past influenza infections or vaccination increased the likelihood of vaccination (p < .001). CONCLUSIONS: The COVID-19 pandemic was associated with increased influenza vaccine utilization. Disparities persisted but narrowed with respect to gender and race but worsened with respect to income and educational attainment. Elsevier Ltd. 2022-04-26 2022-03-29 /pmc/articles/PMC8960160/ /pubmed/35370018 http://dx.doi.org/10.1016/j.vaccine.2022.03.058 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Li, Kun
Yu, Tianzhou
Seabury, Seth A.
Dor, Avi
Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic
title Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic
title_full Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic
title_fullStr Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic
title_full_unstemmed Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic
title_short Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic
title_sort trends and disparities in the utilization of influenza vaccines among commercially insured us adults during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960160/
https://www.ncbi.nlm.nih.gov/pubmed/35370018
http://dx.doi.org/10.1016/j.vaccine.2022.03.058
work_keys_str_mv AT likun trendsanddisparitiesintheutilizationofinfluenzavaccinesamongcommerciallyinsuredusadultsduringthecovid19pandemic
AT yutianzhou trendsanddisparitiesintheutilizationofinfluenzavaccinesamongcommerciallyinsuredusadultsduringthecovid19pandemic
AT seaburysetha trendsanddisparitiesintheutilizationofinfluenzavaccinesamongcommerciallyinsuredusadultsduringthecovid19pandemic
AT doravi trendsanddisparitiesintheutilizationofinfluenzavaccinesamongcommerciallyinsuredusadultsduringthecovid19pandemic